chrX-54809806-A-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_177433.3(MAGED2):​c.130A>G​(p.Lys44Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00455 in 1,200,730 control chromosomes in the GnomAD database, including 11 homozygotes. There are 1,745 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., 74 hem., cov: 22)
Exomes 𝑓: 0.0047 ( 10 hom. 1671 hem. )

Consequence

MAGED2
NM_177433.3 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.21

Publications

4 publications found
Variant links:
Genes affected
MAGED2 (HGNC:16353): (MAGE family member D2) This gene is a member of the MAGED gene family. The MAGED genes are clustered on chromosome Xp11. This gene is located in Xp11.2, a hot spot for X-linked intellectual disability (XLID). Mutations in this gene cause a form of transient antenatal Bartter's syndrome. This gene may also be involved in several types of cancer, including breast cancer and melanoma. The protein encoded by this gene is progressively recruited from the cytoplasm to the nucleoplasm during the interphase and after nucleolar stress and is thus thought to play a role in cell cycle regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
MAGED2 Gene-Disease associations (from GenCC):
  • Bartter disease type 5
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • antenatal Bartter syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0052116513).
BP6
Variant X-54809806-A-G is Benign according to our data. Variant chrX-54809806-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445992.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 74 XL,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGED2NM_177433.3 linkc.130A>G p.Lys44Glu missense_variant Exon 3 of 13 ENST00000375068.6 NP_803182.1 Q9UNF1-1A0A024R9Y7
MAGED2NM_014599.6 linkc.130A>G p.Lys44Glu missense_variant Exon 3 of 13 NP_055414.2 Q9UNF1-1A0A024R9Y7
MAGED2NM_201222.3 linkc.130A>G p.Lys44Glu missense_variant Exon 3 of 13 NP_957516.1 Q9UNF1-1A0A024R9Y7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGED2ENST00000375068.6 linkc.130A>G p.Lys44Glu missense_variant Exon 3 of 13 1 NM_177433.3 ENSP00000364209.1 Q9UNF1-1

Frequencies

GnomAD3 genomes
AF:
0.00272
AC:
301
AN:
110849
Hom.:
1
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000791
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000857
Gnomad ASJ
AF:
0.00151
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000787
Gnomad FIN
AF:
0.00101
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00478
Gnomad OTH
AF:
0.00200
GnomAD2 exomes
AF:
0.00317
AC:
520
AN:
163982
AF XY:
0.00340
show subpopulations
Gnomad AFR exome
AF:
0.000682
Gnomad AMR exome
AF:
0.000777
Gnomad ASJ exome
AF:
0.00209
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000820
Gnomad NFE exome
AF:
0.00591
Gnomad OTH exome
AF:
0.00312
GnomAD4 exome
AF:
0.00474
AC:
5166
AN:
1089826
Hom.:
10
Cov.:
31
AF XY:
0.00469
AC XY:
1671
AN XY:
356358
show subpopulations
African (AFR)
AF:
0.000647
AC:
17
AN:
26257
American (AMR)
AF:
0.000731
AC:
25
AN:
34220
Ashkenazi Jewish (ASJ)
AF:
0.00208
AC:
40
AN:
19232
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29921
South Asian (SAS)
AF:
0.00180
AC:
95
AN:
52709
European-Finnish (FIN)
AF:
0.00110
AC:
44
AN:
39999
Middle Eastern (MID)
AF:
0.000243
AC:
1
AN:
4112
European-Non Finnish (NFE)
AF:
0.00571
AC:
4783
AN:
837580
Other (OTH)
AF:
0.00352
AC:
161
AN:
45796
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
187
374
562
749
936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00271
AC:
301
AN:
110904
Hom.:
1
Cov.:
22
AF XY:
0.00223
AC XY:
74
AN XY:
33126
show subpopulations
African (AFR)
AF:
0.000789
AC:
24
AN:
30413
American (AMR)
AF:
0.000856
AC:
9
AN:
10511
Ashkenazi Jewish (ASJ)
AF:
0.00151
AC:
4
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3514
South Asian (SAS)
AF:
0.000788
AC:
2
AN:
2537
European-Finnish (FIN)
AF:
0.00101
AC:
6
AN:
5967
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00478
AC:
253
AN:
52901
Other (OTH)
AF:
0.00197
AC:
3
AN:
1522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00401
Hom.:
183
Bravo
AF:
0.00263
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00554
AC:
16
ESP6500AA
AF:
0.00156
AC:
6
ESP6500EA
AF:
0.00505
AC:
34
ExAC
AF:
0.00306
AC:
370

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 16, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.019
T;T;T;T;T;T;T;T
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.70
.;T;.;T;T;.;.;.
M_CAP
Benign
0.0077
T
MetaRNN
Benign
0.0052
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.1
L;.;L;.;L;L;.;L
PhyloP100
1.2
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.43
N;.;N;N;N;N;N;N
REVEL
Benign
0.22
Sift
Uncertain
0.0020
D;.;D;D;D;D;T;D
Sift4G
Benign
1.0
T;T;T;T;T;T;T;T
Polyphen
0.98
D;P;D;.;D;D;P;D
Vest4
0.068
MVP
0.66
MPC
0.88
ClinPred
0.027
T
GERP RS
3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.26
gMVP
0.44
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11555928; hg19: chrX-54836239; COSMIC: COSV107262428; COSMIC: COSV107262428; API